HLA-DRB1*1101 allele may be associated with bilateral Ménière's disease in southern European population

Otology and Neurotology

Volumn 28, Issue 7, 2007, Pages 891-895

  Lopez Escamez, Jose A ^a   Vilchez, Jose R ^b   Soto Varela, Andres ^c   Santos Perez, Sofia ^c   Perez Garrigues, Herminio ^d   Aran, Ismael ^e   Lopez Nevot, Miguel A ^b  

^a HOSPITAL DE PONIENTE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e Complejo Hospitalario de Pontevedra ^*  (Spain)

Author keywords

Class II alleles; Controlled studies; HLA genes; Inner ear; Sensorineural hearing loss; Vertigo

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DQ ANTIGEN; HLA-DRB1 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ETHNICITY; FEMALE; GENE AMPLIFICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MENIERE DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RATING SCALE; SOUTHERN EUROPE; AGED; ETHNIC GROUP; EUROPE; GENE FREQUENCY; GENETICS; HISTOCOMPATIBILITY TEST; MIDDLE AGED; MULTICENTER STUDY; PERCEPTION DEAFNESS; PROSPECTIVE STUDY; SPAIN;

AGED; ALLELES; ETHNIC GROUPS; EUROPE; FEMALE; GENE FREQUENCY; HEARING LOSS, SENSORINEURAL; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PROSPECTIVE STUDIES; SPAIN;

EID: 34848835496     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3180dca1cc     Document Type: Article

References (29)

1. Robinson J, Waller MJ, Parham P, et al. IMGT/HLA and IMGT/MCH: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 2003;31:311-4.
2. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
3. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leucocyte antigen DRβ1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 2002;31:355-60.
4. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585-9.
5. Harris JP, Weisman MH, Derebery JM, et al. Treatment of corticosteroids-responsive autoimmune inner ear disease with methorexate: a randomized controlled trial. JAMA 2003;290:1875-83.
6. Amor-Dorado JC, Paco L, Martin J, Lopez-Nevot MA, Gonzales-Gay MA. Human leukocyte antigen-DQB1 and -DRB1 associations in patients with idiopathic sudden sensorineural hearing loss from a defined population of Northwest Spain. Acta Otolaryngol 2005;125:1277-82.
7. Hughes GB, Kinney SE, Barna BP, Calabrese LH. Autoimmune reactivity in Ménière's disease: a preliminary report. Laryngoscope 1983;93:410-7.
8. Xenellis J, Morrison AW, McClowskey D, Festenstein H. HLA antigens in the pathogenesis of Ménière's disease. J Laryngol Otol 1986;100:21-4.
9. Koyama S, Mitsuishi Y, Bibee K, Watanabe I. HLA associations with Ménière' disease. Acta Otolaryngol (Stockh) 1993;113:575-8.
10. Yeo SW, Park S, Jeon E, Lee HY, Pyo CW, Ki TG. Influence of human leucocyte antigen in the pathogenesis of Ménière's disease in the South Korean population. Acta Otolaryngol 2002;122:851-6.
11. Lopez-Escamez JA, Lopez-Nevot A, Cortes R, Ramal L, Lopez-Nevot MA. Expression of A, B, C and DR antigens in definite Ménière disease in a Spanish population. Eur Arch Otorhinolaryngol 2002;259:347-50.
12. Paparella MM, Griebie MS. Bilaterality of Ménière's disease. Acta Otolaryngol 1984;97:233-7.
13. Salvinelli F, Trivelli M, Greco F, Silvestrini M, Fernandez E, Pallini R. Ménière's disease: is it a bilateral disease? Eur Rev Med Pharmacol Sci 1990;3:129-33.
14. Kodama A, Kitahara M, Kitanishi T. Clinical findings in Ménière's disease with bilateral fluctuant hearing loss. Acta Otolryngol Suppl 1995;519:227-9.
15. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
16. Pascual M, Nieto A, López-Nevot MA, et al. Rheumatoid arthritis in southern Spain: toward elucidation of a unifying role of the HLA class II region in disease predisposition. Arthritis Rheum 2001;44:307-14.
17. Bernstein JM, Shanahan TC, Schaffer FM. Further observations on the role of the MHC genes and certain hearing disorders. Acta Otolaryngol (Stockh) 1996;116:666-71.
18. Cao MY, Thonnard J, Deggouj N, Gersdorff M, Tomasi JP. HLA class IIYassociated genetic susceptibility in idiopathic progressive sensorineural hearing loss. Ann Otol Rhinol Laryngol 1996;105:628-33.
19. Morrison AW, Mowbray JF, Williamson R, Sheeka S, Sodha N, Koskinen N. On genetic and environmental factors in Ménière's disease. Am J Otol 1994;15:35-9.
20. Fransen E, Vertreken M, Verhagen WI, et al. High prevalence of symptoms of Ménière's disease in three families with a mutation in the COCH gene. Hum Mol Genet 1999;8:1425-9.
21. Sanchez E, Lopez-Escamez JA, Lopez-Nevot A, Cortes R, Martin J. Absence of COCH mutations in patients with Ménière' disease. Eur J Hum Genet 2004;12:75-8.
22. Usami S, Takahashi K, Yuge I, et al. Mutations in the COCH gene are a frequent cause of autosomal dominant progresive cochleovestibular dysfunction, but not of Ménière's disease. Eur J Hum Genet 2003;11:744-8.
23. Brooks GB. Circulating immune complexes in Ménière's disease. Arch Otolaryngol Head Neck Surg 1986;112:536-40.
24. Derebery MJ, Rao VS, Siglock TJ, Linthicum FH, Nelson RA. Ménière's disease: an immune complex-mediated illness? Laryngoscope 1991;101:225-9.
25. Hausler R, Arnorld W, Schfferlic J. C3 and C1q complement deposits in the membranous labyrinth of patients with Ménière's disease. Adv Otorhinolaryngol 1988;42:116-22.
26. Ruckestein MJ, Prasthoffer A, Bigelow DC, Von Feldt JM, Kolasinski SL. Immunologic and serologic testing in patients with Ménière's disease. Otol Neurotol 2002;23:517-21.
27. Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harris JP. Assessment of serum antibodies in patients with rapidly progressive sensorineural hearing loss and Ménière's disease. Laryngoscope 1995;105:1347-52.
28. Rauch SD, San Martin JE, Moscicki RA, Bloch KJ. Serum antibodies against heat shock protein in Ménière's disease. Am J Otol 1995;16:648-52.
29. Passali D, Damiani V, Mora R, Passali FM, Passali GC, Bellussi L. P0 antigen detection in sudden hearing loss and Ménière's disease: a new diagnostic marker? Acta Otolaryngol 2004;124:1145-8.